(1)

Commission Delegated Regulation (EU) No 1062/2014 (2) establishes a list of existing active substances to be evaluated for their possible approval for use in biocidal products. That list includes garlic extract (extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Allium sativum, Liliaceae) (CAS No: 8008-99-9) for product-type 19.

(2)

Garlic extract has been evaluated for use in biocidal products of product-type 19 (repellents and attractants), as described in Annex V to Regulation (EU) No 528/2012.

(3)

Austria was designated as the rapporteur Member State and its evaluating competent authority submitted the assessment report together with its conclusions to the European Chemicals Agency (‘the Agency’) on 23 September 2022. The Agency discussed the assessment report and the conclusions in technical meetings.

(4)

During the examination of garlic extract the identity of this active substance has been redefined in accordance with Article 13 of Delegated Regulation (EU) No 1062/2014 to thermally treated garlic juice.

(5)

In accordance with Article 75(1), second subparagraph, point (a), of Regulation (EU) No 528/2012, the Biocidal Products Committee prepares the opinion of the Agency regarding the applications for approval of active substances. In accordance with Article 7(2) of Delegated Regulation (EU) No 1062/2014 read in conjunction with Article 75(1) and (4) of Regulation (EU) No 528/2012, the Biocidal Products Committee adopted the opinion of the Agency on 5 June 2023 (3), having regard to the conclusions of the evaluating competent authority.

(6)

In that opinion, the Agency concludes that biocidal products of product-type 19 containing thermally treated garlic juice may be expected to satisfy the criteria laid down in Article 19(1), point (b), of Regulation (EU) No 528/2012, provided that certain conditions concerning their use are complied with.

(7)

Taking into account the opinion of the Agency, it is appropriate to approve thermally treated garlic juice as an active substance for use in biocidal products of product-type 19 subject to compliance with certain conditions.

(8)

A reasonable period should be allowed to elapse before an active substance is approved in order to permit interested parties to take the preparatory measures necessary to meet the new requirements.

(9)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,